Ascendis Pharma A/S (ASND)
USD 172.06
(2.74%)
USD 172.06
(2.74%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 618.86 Million EUR | 28.14% |
| 2022 | 482.95 Million EUR | 392.98% |
| 2021 | 97.96 Million EUR | 15.1% |
| 2020 | 85.11 Million EUR | 177.07% |
| 2019 | 30.72 Million EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | 0.0% |
| 2015 | - EUR | 0.0% |
| 2014 | - EUR | 0.0% |
| 2013 | - EUR | 0.0% |
| 2012 | - EUR | -100.0% |
| 2011 | 213 Thousand EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 219.18 Million EUR | -4.61% |
| 2024 Q1 | 229.62 Million EUR | -57.02% |
| 2023 Q3 | 639.58 Million EUR | 33.42% |
| 2023 Q4 | 618.86 Million EUR | -3.24% |
| 2023 FY | 618.86 Million EUR | 28.14% |
| 2023 Q1 | 479.98 Million EUR | -0.61% |
| 2023 Q2 | 479.37 Million EUR | -0.13% |
| 2022 FY | 482.95 Million EUR | 392.98% |
| 2022 Q4 | 482.95 Million EUR | -9.41% |
| 2022 Q3 | 533.14 Million EUR | 7.03% |
| 2022 Q2 | 498.13 Million EUR | 7.19% |
| 2022 Q1 | 464.73 Million EUR | 374.38% |
| 2021 FY | 97.96 Million EUR | 15.1% |
| 2021 Q2 | 94.05 Million EUR | 5.01% |
| 2021 Q3 | 95.55 Million EUR | 1.59% |
| 2021 Q4 | 97.96 Million EUR | 2.53% |
| 2021 Q1 | 89.56 Million EUR | 5.23% |
| 2020 Q3 | 26.95 Million EUR | -7.36% |
| 2020 Q4 | 85.11 Million EUR | 215.81% |
| 2020 FY | 85.11 Million EUR | 177.07% |
| 2020 Q1 | 30.76 Million EUR | 0.13% |
| 2020 Q2 | 29.09 Million EUR | -5.42% |
| 2019 Q3 | 31.5 Million EUR | 0.13% |
| 2019 FY | 30.72 Million EUR | 0.0% |
| 2019 Q4 | 30.72 Million EUR | -2.49% |
| 2019 Q2 | 31.46 Million EUR | 138.11% |
| 2019 Q1 | 13.21 Million EUR | 0.0% |
| 2018 FY | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2017 Q1 | - EUR | 0.0% |
| 2017 Q4 | - EUR | 0.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| 2017 Q3 | - EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 Q3 | - EUR | 0.0% |
| 2016 Q1 | - EUR | 0.0% |
| 2016 FY | - EUR | 0.0% |
| 2016 Q4 | - EUR | 0.0% |
| 2015 Q1 | - EUR | 0.0% |
| 2015 Q4 | - EUR | 0.0% |
| 2015 Q3 | - EUR | 0.0% |
| 2015 Q2 | - EUR | 0.0% |
| 2015 FY | - EUR | 0.0% |
| 2014 Q2 | - EUR | 0.0% |
| 2014 Q3 | - EUR | 0.0% |
| 2014 Q4 | - EUR | 0.0% |
| 2014 FY | - EUR | 0.0% |
| 2014 Q1 | - EUR | 0.0% |
| 2013 Q1 | - EUR | 0.0% |
| 2013 Q4 | - EUR | 0.0% |
| 2013 FY | - EUR | 0.0% |
| 2012 FY | - EUR | -100.0% |
| 2011 FY | 213 Thousand EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Absci Corporation | 4.66 Million USD | -13180.365% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -373.645% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 73.587% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -231684.644% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -3104158.628% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -1444.074% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -5430.024% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -515.186% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -3175.284% |
| Chimerix, Inc. | 125 Thousand USD | -494992.0% |
| CRISPR Therapeutics AG | 223 Million USD | -177.509% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -221.288% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -12514.452% |
| Fortress Biotech, Inc. | 60.85 Million USD | -916.933% |
| Fortress Biotech, Inc. | 60.85 Million USD | -916.933% |
| Gritstone bio, Inc. | 40.14 Million USD | -1441.613% |
| Allakos Inc. | 38.21 Million USD | -1519.43% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -149.928% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -1569.044% |
| Cytokinetics, Incorporated | 607.37 Million USD | -1.892% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -6615.115% |
| Innoviva, Inc. | 446.23 Million USD | -38.686% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -2350674.899% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -13782.122% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -4680.726% |
| ImmuCell Corporation | 10.54 Million USD | -5771.308% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -54910.222% |
| Incyte Corporation | 29.16 Million USD | -2022.162% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -5509.693% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -454369.682% |
| Mustang Bio, Inc. | 1.97 Million USD | -31187.412% |
| MiMedx Group, Inc. | 48.09 Million USD | -1186.648% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 30.19 Million USD | -1949.493% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 5.3 Million USD | -11576.698% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -550.143% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -19.309% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -654.559% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -454947.794% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -847660.274% |
| NextCure, Inc. | 5.94 Million USD | -10302.841% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -59520.906% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 118.85 Thousand USD | -520580.313% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -426703.448% |
| Opthea Limited | 200.53 Million USD | -208.606% |
| Ovid Therapeutics Inc. | 30 Million USD | -1962.883% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| PDS Biotechnology Corporation | 19.5 Million USD | -3072.661% |
| Precigen, Inc. | 5.89 Million USD | -10398.134% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -14103.925% |
| PureTech Health plc | 18.25 Million USD | -3291.041% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -2671.948% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 77.104% |
| Replimune Group, Inc. | 71.99 Million USD | -759.654% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -1075.254% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -1616115.299% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -668.061% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -1746.531% |
| Solid Biosciences Inc. | 23.94 Million USD | -2484.959% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -105149.15% |
| SciSparc Ltd. | 24 Thousand USD | -2578504.167% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -315.028% |
| TG Therapeutics, Inc. | 100.11 Million USD | -518.136% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -9332.48% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -64.041% |
| UroGen Pharma Ltd. | 98.55 Million USD | -527.964% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -1343.451% |
| XOMA Corporation | 118.51 Million USD | -422.17% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -1334.218% |
| AbCellera Biologics Inc. | 71.22 Million USD | -768.924% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -19008.846% |
| Precision BioSciences, Inc. | 7.72 Million USD | -7913.272% |
| Dyadic International, Inc. | 88.87 Thousand USD | -696271.104% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -448352.899% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -2812922.727% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -625016.162% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -7535.595% |
| IGM Biosciences, Inc. | 34.67 Million USD | -1684.913% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -1034.075% |
| Acelyrin, Inc. | 1.19 Million USD | -51731.24% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -13958.723% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -10653.519% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -686581.683% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -2288.795% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -1690.905% |
| Senti Biosciences, Inc. | 33.53 Million USD | -1745.265% |
| Mesoblast Limited | 100.48 Million USD | -515.89% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -690.084% |
| ChromaDex Corporation | 2.57 Million USD | -23933.592% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -769.241% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -2283.55% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -224.128% |
| Novavax, Inc. | 168.01 Million USD | -268.337% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -535.646% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -987.751% |
| Celcuity Inc. | 37.03 Million USD | -1571.009% |
| ContextLogic Inc. | 6 Million USD | -10214.417% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -347.467% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -16181.636% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 87.884% |
| Amarin Corporation plc | 8.73 Million USD | -6983.267% |
| AnaptysBio, Inc. | 16.03 Million USD | -3758.982% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -11366.833% |
| Aptorum Group Limited | 3.05 Million USD | -20134.265% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -6941.359% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -491.604% |
| Ardelyx, Inc. | 51.54 Million USD | -1100.584% |
| Celularity Inc. | 26.17 Million USD | -2264.156% |
| Omeros Corporation | 329.7 Million USD | -87.703% |
| Humacyte, Inc. | 38.6 Million USD | -1503.277% |
| Immunocore Holdings plc | 82.64 Million USD | -648.832% |
| IO Biotech, Inc. | 1.83 Million USD | -33552.257% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -42346.159% |
| Summit Therapeutics Inc. | 103.29 Million USD | -499.153% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 8.32 Million USD | -7332.028% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -539.674% |
| Evogene Ltd. | 10.65 Million USD | -5709.303% |
| CorMedix Inc. | 517.01 Thousand USD | -119600.085% |
| BioLineRx Ltd. | 6.62 Million USD | -9237.13% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -39318.153% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -117.747% |
| scPharmaceuticals Inc. | 38.81 Million USD | -1494.561% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -7071.92% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -2379.03% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -4125666.667% |
| Lisata Therapeutics, Inc. | 137.00 USD | -451726177.372% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -12865.954% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -96296.417% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -15712.883% |
| bluebird bio, Inc. | 224.41 Million USD | -175.763% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -4.345% |
| DBV Technologies S.A. | 4.52 Million USD | -13573.553% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -9860.808% |
| Galecto, Inc. | 66 Thousand USD | -937574.242% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -16319.873% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -35943.39% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -199.015% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -925734.779% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -206.674% |
| ADMA Biologics, Inc. | 130.59 Million USD | -373.885% |
| Clene Inc. | 7.15 Million USD | -8553.034% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -56109.355% |
| Aptose Biosciences Inc. | 621 Thousand USD | -99556.2% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -61117.152% |
| Century Therapeutics, Inc. | 46.65 Million USD | -1226.386% |
| Kura Oncology, Inc. | 9.33 Million USD | -6531.644% |
| Surrozen, Inc. | 882 Thousand USD | -70066.1% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -2217.846% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -6494.193% |
| Autolus Therapeutics plc | 47.91 Million USD | -1191.616% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -9037.236% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -2288.702% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -2587.796% |
| INmune Bio, Inc. | 397 Thousand USD | -155785.39% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -256.175% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -15164.561% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -1896.79% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -421042.709% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -1143.4% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -1373.909% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -1254.398% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -30.736% |
| Verastem, Inc. | 40.08 Million USD | -1443.843% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -6055.411% |
| Histogen Inc. | 4.38 Million USD | -14016.446% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -1194.697% |
| Surrozen, Inc. | 882 Thousand USD | -70066.1% |
| Organovo Holdings, Inc. | 888 Thousand USD | -69592.005% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -717.523% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -664602.913% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -2338.492% |
| Turnstone Biologics Corp. | 1.18 Million USD | -51949.201% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -567666.055% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -925.953% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -654.631% |
| Exelixis, Inc. | 189.94 Million USD | -225.814% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -2576.173% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -565.21% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -34016.042% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -302.925% |
| Insmed Incorporated | 1.19 Billion USD | 48.141% |
| MediWound Ltd. | 6.35 Million USD | -9645.906% |
| OmniAb, Inc. | 22.07 Million USD | -2703.465% |
| Alector, Inc. | 30.45 Million USD | -1931.997% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -509.455% |
| Zai Lab Limited | 8.04 Million USD | -7590.63% |
| AlloVir, Inc. | 16.64 Million USD | -3617.353% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -45.071% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -8294565.594% |
| Aura Biosciences, Inc. | 16.87 Million USD | -3568.435% |
| Immunic, Inc. | 639 Thousand USD | -96748.983% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -1975.405% |
| Veracyte, Inc. | 7.52 Million USD | -8124.12% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 4.032% |
| FibroGen, Inc. | 89.69 Million USD | -589.951% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -14169.426% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -19312.327% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -472810.601% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1672508.108% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -31155.808% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 62.089% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -10188.695% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -34016.042% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -4504.993% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -134435.87% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -2785.555% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -1592.969% |
| Agenus Inc. | 137.32 Million USD | -350.66% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -119603.095% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1268.081% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -1924.155% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -1281.333% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 23.716% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -137715.581% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -841.139% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -195743.354% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -1006250.007% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 5.92 Million USD | -10351.054% |
| Pluri Inc. | 29.05 Million USD | -2030.124% |
| Prothena Corporation plc | 10.72 Million USD | -5672.456% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -3017.551% |
| Rallybio Corporation | 173 Thousand USD | -357625.434% |
| Kodiak Sciences Inc. | 100 Million USD | -518.865% |
| Cue Biopharma, Inc. | 4.2 Million USD | -14627.868% |
| MeiraGTx Holdings plc | 72.11 Million USD | -758.116% |
| Annexon, Inc. | 29.19 Million USD | -2020.127% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -55057.308% |
| Moderna, Inc. | - USD | -Infinity% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -38267.328% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -17201.23% |
| Blueprint Medicines Corporation | 610.96 Million USD | -1.294% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -1343.35% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -1171.188% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -2336.093% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -580.812% |
| Elicio Therapeutics, Inc. | 6 Million USD | -10202.397% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -131854.158% |
| Nutriband Inc. | 79.82 Thousand USD | -775167.457% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -13701.628% |
| Vor Biopharma Inc. | 31.83 Million USD | -1844.282% |
| Roivant Sciences Ltd. | 477.85 Million USD | -29.509% |
| Alkermes plc | 287.73 Million USD | -115.085% |
| ProKidney Corp. | 3.61 Million USD | -17043.075% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -81436.891% |
| Arcellx, Inc. | 50.84 Million USD | -1117.256% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 64.345% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -1579.964% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -762.638% |
| Atai Life Sciences N.V. | 15.21 Million USD | -3968.536% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -73365.465% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -242592.157% |
| MediciNova, Inc. | 410.66 Thousand USD | -150600.093% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -45105.625% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -93229.201% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -247.54% |
| Biomea Fusion, Inc. | 7.83 Million USD | -7803.768% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -28684.419% |
| Geron Corporation | 35.05 Million USD | -1665.613% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -5271.16% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -2626.878% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -6085.557% |
| Royalty Pharma plc | 6.13 Billion USD | 89.913% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -5279.096% |
| Imunon, Inc. | 1.13 Million USD | -54220.091% |
| BioAtla, Inc. | 836 Thousand USD | -73926.914% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -600.501% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -13042.175% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -2573.514% |
| Structure Therapeutics Inc. | 4.01 Million USD | -15321.505% |
| 89bio, Inc. | 24.79 Million USD | -2395.927% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -6046.241% |
| aTyr Pharma, Inc. | 13.76 Million USD | -4395.279% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -7734.726% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -2962.93% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -222361.267% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4181.363% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 58.722% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -521.925% |
| Liquidia Corporation | 2.36 Million USD | -26078.723% |
| Entera Bio Ltd. | 256 Thousand USD | -241644.141% |
| GH Research PLC | 631 Thousand USD | -97976.862% |
| Vericel Corporation | 81.85 Million USD | -656.041% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -8800.69% |
| Xencor, Inc. | 14.64 Million USD | -4126.643% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -411787.442% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -412476.667% |
| Vaxcyte, Inc. | 22.11 Million USD | -2698.901% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -6343.825% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -8733.357% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -454369.682% |
| Portage Biotech Inc. | 7000.00 USD | -8840828.571% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -93229.201% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -43207.558% |
| OncoCyte Corporation | 2.2 Million USD | -27979.174% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -924890.658% |
| Purple Biotech Ltd. | 163 Thousand USD | -379571.779% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -9779.709% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -51215.506% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -126198.98% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -24312.821% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -130462.236% |
| United Therapeutics Corporation | 300 Million USD | -106.288% |
| HilleVax, Inc. | 25.24 Million USD | -2351.533% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -272.575% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -66230.654% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -33298.003% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -2979.084% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -2248.812% |
| Windtree Therapeutics, Inc. | 15 Million USD | -4025.767% |
| Curis, Inc. | 1.48 Million USD | -41462.458% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -88598.824% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -10314316.667% |
| BeiGene, Ltd. | 197.61 Million USD | -213.162% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -1092.671% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -46083.955% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -16328.59% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -66588.039% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -3443.053% |
| Adicet Bio, Inc. | 17.7 Million USD | -3395.82% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -59.56% |
| Aditxt, Inc. | 1.04 Million USD | -59306.63% |
| Adagene Inc. | 13.54 Million USD | -4470.631% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4405.096% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -3520.576% |
| Compugen Ltd. | 719 Thousand USD | -85973.018% |
| Generation Bio Co. | 89.77 Million USD | -589.359% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -2689.565% |
| Invivyd, Inc. | 722 Thousand USD | -85615.374% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -1175.958% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -21166868.222% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -16079.477% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -2690617.391% |
| 2seventy bio, Inc. | 244.01 Million USD | -153.62% |
| Instil Bio, Inc. | 81.42 Million USD | -660.024% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -18229.903% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -944890.762% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -235330.734% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -6320.427% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -454.176% |
| Evaxion Biotech A/S | 8.48 Million USD | -7190.415% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -725.979% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -856.293% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -9856.001% |
| Cingulate Inc. | 135.09 Thousand USD | -457982.591% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -2529.105% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -343713.889% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -3449.148% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -66018.056% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -435.907% |
| ImmunityBio, Inc. | 836.95 Million USD | 26.057% |
| Korro Bio, Inc. | 31.21 Million USD | -1882.525% |
| Kineta, Inc. | 150 Thousand USD | -412476.667% |
| BioVie Inc. | 349.89 Thousand USD | -176772.138% |
| Codexis, Inc. | 12.24 Million USD | -4954.848% |
| Celularity Inc. | 26.17 Million USD | -2264.156% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -577.021% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -1201.367% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -350839.919% |
| Cibus, Inc. | 17.67 Million USD | -3401.556% |
| IN8bio, Inc. | 3.37 Million USD | -18215.034% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -857.595% |
| Avalo Therapeutics, Inc. | 2 Million USD | -30843.25% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 55.807% |
| Eyenovia, Inc. | 8.95 Million USD | -6809.111% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -842.544% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1953.506% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -7500.897% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -42346.159% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -2813.951% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -58560.19% |
| Moolec Science SA | 99.04 Thousand USD | -624725.838% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -2140.56% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -104614.89% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -37589.708% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -115359.888% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -1949572.358% |
| Humacyte, Inc. | 38.6 Million USD | -1503.277% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -4877.2% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -33065.327% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -59867.539% |
| Notable Labs, Ltd. | 1.52 Million USD | -40454.718% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4405.096% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -195125.552% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -1140.782% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -475950.0% |
| PepGen Inc. | 17.1 Million USD | -3519.094% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -14766.37% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -106970.069% |
| XOMA Corporation | 118.51 Million USD | -422.17% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -1672508.108% |
| Bionomics Limited | 117.62 Million USD | -426.12% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -10931.462% |
| uniQure N.V. | 130.06 Million USD | -375.812% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -956.264% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -90113.557% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -14169.426% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -44583.394% |
| Altimmune, Inc. | 175 Thousand USD | -353537.143% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -10931.462% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -12116.048% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -631.908% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -6132.276% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -9601.599% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -6132.276% |
| argenx SE | 15.35 Million USD | -3930.643% |
| Immunome, Inc. | 1.34 Million USD | -46083.955% |
| Verona Pharma plc | 48.37 Million USD | -1179.334% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -6615.115% |
| Shattuck Labs, Inc. | 3.4 Million USD | -18069.847% |
| CervoMed Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -727976.471% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -368272.024% |
| Moolec Science SA | 99.04 Thousand USD | -624725.838% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -26415.21% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Achilles Therapeutics plc | 1.07 Million USD | -57415.335% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -4760400.0% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -80.7% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -2427.63% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -24654.699% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -318902.577% |
| Beam Therapeutics Inc. | 159.91 Million USD | -287.006% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -101.966% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -74193.517% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -1034410.715% |
| NeurAxis, Inc. | 27.07 Thousand USD | -2285981.046% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -61786.5% |
| Lumos Pharma, Inc. | 6 Million USD | -10214.417% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -3596.387% |
| Palisade Bio, Inc. | 90 Thousand USD | -687527.778% |
| Nutriband Inc. | 79.82 Thousand USD | -775167.457% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -1427.76% |
| Neurogene Inc. | 13.37 Million USD | -4527.72% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -2256.414% |
| Athira Pharma, Inc. | 1.21 Million USD | -50751.684% |
| HCW Biologics Inc. | 6.3 Million USD | -9716.526% |
| XOMA Corporation | 118.51 Million USD | -422.17% |
| Nektar Therapeutics | 112.62 Million USD | -449.492% |
| Arvinas, Inc. | 800 Thousand USD | -77258.125% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4181.363% |
| Merus N.V. | 10.48 Million USD | -5800.696% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -4057.642% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -4508.422% |
| Rezolute, Inc. | 1.66 Million USD | -37181.024% |
| Clene Inc. | 7.15 Million USD | -8553.034% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -843638.071% |
| BeyondSpring Inc. | 3.36 Million USD | -18296.7% |
| Synlogic, Inc. | 12.49 Million USD | -4854.487% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -1795.104% |
| Krystal Biotech, Inc. | 6.62 Million USD | -9248.414% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -262.081% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -10221.298% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1306321.65% |
| MannKind Corporation | 252.15 Million USD | -145.434% |
| Ikena Oncology, Inc. | 7.18 Million USD | -8519.29% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -310887.437% |
| Gossamer Bio, Inc. | 197.4 Million USD | -213.5% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -118912.5% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -119.98% |
| Mural Oncology plc | 8.91 Million USD | -6844.956% |
| Disc Medicine, Inc. | 1.43 Million USD | -42996.448% |
| Champions Oncology, Inc. | 6.09 Million USD | -10056.983% |
| REGENXBIO Inc. | 82.22 Million USD | -652.676% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -125175.555% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -13857.262% |
| Vaxart, Inc. | 2.62 Million USD | -23493.786% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -227732.979% |
| Cellectis S.A. | 36.24 Million USD | -1607.638% |
| Longeveron Inc. | 1.44 Million USD | -42639.296% |
| Repare Therapeutics Inc. | 1.01 Million USD | -61173.762% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 45.355% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -1282.352% |
| Revolution Medicines, Inc. | 80.57 Million USD | -668.061% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -19191.303% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -349541.243% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -503042.276% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 14.604% |
| Denali Therapeutics Inc. | 44.98 Million USD | -1275.836% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -4849.237% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -457982.591% |
| Passage Bio, Inc. | 22.92 Million USD | -2599.991% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -10147.806% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -95551.468% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -2969.006% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -151784.739% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -51993.013% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -132703.648% |
| OmniAb, Inc. | 22.07 Million USD | -2703.465% |
| Anew Medical, Inc. | 1.54 Million USD | -40086.039% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -1993.59% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -6751.157% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -1890.56% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -15164.561% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -1100.351% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -9619.884% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4280.105% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -91993.006% |
| Alumis Inc. Common Stock | 30.86 Million USD | -1905.395% |
| Equillium, Inc. | 384 Thousand USD | -161062.76% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -9948.141% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -20338.078% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -3129748.784% |
| vTv Therapeutics Inc. | 169 Thousand USD | -366092.308% |
| Bio-Techne Corporation | 319 Million USD | -94.002% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -985.957% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -246.575% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -3916.778% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -4897.698% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -12774.246% |
| Nkarta, Inc. | 82.27 Million USD | -652.237% |
| BioCardia, Inc. | 982 Thousand USD | -62920.876% |
| Iterum Therapeutics plc | 18.95 Million USD | -3164.745% |